"While there are many changes in the LCD that are beneficial to patients, the reduction of the number of skin substitute applications from 10 to 4 over a twelve-week treatment period has been universally perceived amongst wound care specialists, researchers and patient advocate groups as a decision that will unfavorably impact patient outcomes while concurrently increasing overall healthcare expenditures."
This article by CEO Shaun Carpenter, MD, CWSP discusses new products released by the Medicare Administrative Contractors (MAC) that are not as beneficial for all wound sizes, as well as temporary solutions.
READ THE FULL ARTICLE
